从患有或未患有囊性纤维化的患者中分离出的洋葱伯克霍尔德菌复合体菌种的分布情况。
Distribution of Burkholderia cepacia complex species among isolates recovered from persons with or without cystic fibrosis.
作者信息
Reik Rebecca, Spilker Theodore, Lipuma John J
机构信息
Department of Pediatrics and Communicable Diseases, University of Michigan Medical School, 1150 W. Medical Center Dr., 8323 MSRB III, Box 0646, Ann Arbor, MI 48109-0646, USA.
出版信息
J Clin Microbiol. 2005 Jun;43(6):2926-8. doi: 10.1128/JCM.43.6.2926-2928.2005.
Abstract
We analyzed Burkholderia cepacia complex isolates recovered from 1,218 cystic fibrosis (CF) patients and 90 patients without CF. Although all B. cepacia complex species were found, some were rarely identified. The distribution of species differed between the CF and non-CF populations and appears to be changing over time among CF patients.
摘要
我们分析了从1218例囊性纤维化（CF）患者和90例非CF患者中分离出的洋葱伯克霍尔德菌复合体菌株。虽然发现了所有洋葱伯克霍尔德菌复合体菌种，但有些菌种很少被鉴定出来。CF患者群体和非CF患者群体之间的菌种分布有所不同，而且在CF患者中似乎随时间而变化。
相似文献
1
Distribution of Burkholderia cepacia complex species among isolates recovered from persons with or without cystic fibrosis.
J Clin Microbiol. 2005 Jun;43(6):2926-8. doi: 10.1128/JCM.43.6.2926-2928.2005.
2
Species distribution and ribotype diversity of Burkholderia cepacia complex isolates from French patients with cystic fibrosis.
J Clin Microbiol. 2004 Oct;42(10):4824-7. doi: 10.1128/JCM.42.10.4824-4827.2004.
3
Burkholderia cepacia complex epidemiology in persons with cystic fibrosis from Australia and New Zealand.
Res Microbiol. 2008 Apr;159(3):194-9. doi: 10.1016/j.resmic.2008.01.001. Epub 2008 Feb 2.
4
Prevalence of indeterminate genetic species of Burkholderia cepacia complex in a cystic fibrosis center in Argentina.
J Clin Microbiol. 2008 Mar;46(3):1151-2. doi: 10.1128/JCM.01595-07. Epub 2008 Jan 16.
5
Species distribution of Burkholderia cepacia complex isolates in cystic fibrosis and non-cystic fibrosis patients in New Zealand.
J Cyst Fibros. 2010 Dec;9(6):442-6. doi: 10.1016/j.jcf.2010.08.011. Epub 2010 Sep 15.
6
Transmission of Burkholderia cepacia complex: evidence for new epidemic clones infecting cystic fibrosis patients in Italy.
J Clin Microbiol. 2005 Oct;43(10):5136-42. doi: 10.1128/JCM.43.10.5136-5142.2005.
7
Molecular characterization of Burkholderia cepacia isolates from cystic fibrosis (CF) patients in an Italian CF center.
Res Microbiol. 2003 Sep;154(7):491-8. doi: 10.1016/S0923-2508(03)00145-1.
8
Taxon K, a complex within the Burkholderia cepacia complex, comprises at least two novel species, Burkholderia contaminans sp. nov. and Burkholderia lata sp. nov.
Int J Syst Evol Microbiol. 2009 Jan;59(Pt 1):102-11. doi: 10.1099/ijs.0.001123-0.
9
Burkholderia cepacia complex in cystic fibrosis: frequency of strain replacement during chronic infection.
Clin Infect Dis. 2003 Sep 15;37(6):780-5. doi: 10.1086/377541. Epub 2003 Aug 23.
10
Burkholderia cepacia complex infection in a cohort of Italian patients with cystic fibrosis.
J Microbiol. 2007 Jun;45(3):275-9.
引用本文的文献
1
Antimicrobial Agent Trimethoprim Influences Chemical Interactions in Cystic Fibrosis Pathogens via the Gene Cluster.
ACS Chem Biol. 2025 Jun 20;20(6):1153-1170. doi: 10.1021/acschembio.4c00562. Epub 2025 May 9.
2
Colony morphotype variation in implications for success of applications and therapeutics.
J Bacteriol. 2025 May 22;207(5):e0052124. doi: 10.1128/jb.00521-24. Epub 2025 Apr 14.
3
Soleris® Automated System for the Rapid Detection of Burkholderia cepacia Complex in Cosmetic Products.
J AOAC Int. 2022 Dec 22;106(1):171-178. doi: 10.1093/jaoacint/qsac109.
4
Clinical and Microbiological Profile of Patients with Bloodstream Infections Caused by Complex.
J Lab Physicians. 2022 Feb 9;14(3):312-316. doi: 10.1055/s-0042-1742634. eCollection 2022 Sep.
5
Bacterial lectin BambL acts as a B cell superantigen.
Cell Mol Life Sci. 2021 Dec;78(24):8165-8186. doi: 10.1007/s00018-021-04009-z. Epub 2021 Nov 3.
6
Interactions Between Pathogenic and the Complement System: A Review of Potential Immune Evasion Mechanisms.
Front Cell Infect Microbiol. 2021 Sep 30;11:701362. doi: 10.3389/fcimb.2021.701362. eCollection 2021.
7
Advances in Phage Therapy: Targeting the Complex.
Viruses. 2021 Jul 9;13(7):1331. doi: 10.3390/v13071331.
8
Coming from the Wild: Multidrug Resistant Opportunistic Pathogens Presenting a Primary, Not Human-Linked, Environmental Habitat.
Int J Mol Sci. 2021 Jul 28;22(15):8080. doi: 10.3390/ijms22158080.
9
Complex Bacteria: a Feared Contamination Risk in Water-Based Pharmaceutical Products.
Clin Microbiol Rev. 2020 Apr 15;33(3). doi: 10.1128/CMR.00139-19. Print 2020 Jun 17.
10
Loss of -Linked Protein Glycosylation in Burkholderia cenocepacia Impairs Biofilm Formation and Siderophore Activity and Alters Transcriptional Regulators.
mSphere. 2019 Nov 13;4(6):e00660-19. doi: 10.1128/mSphere.00660-19.
本文引用的文献
1
Species abundance and diversity of Burkholderia cepacia complex in the environment.
Appl Environ Microbiol. 2005 Mar;71(3):1193-201. doi: 10.1128/AEM.71.3.1193-1201.2005.
2
Polyphasic characterisation of Burkholderia cepacia-like isolates leading to the emended description of Burkholderia pyrrocinia.
Syst Appl Microbiol. 2004 Sep;27(5):517-26. doi: 10.1078/0723202041748190.
3
Species distribution and ribotype diversity of Burkholderia cepacia complex isolates from French patients with cystic fibrosis.
J Clin Microbiol. 2004 Oct;42(10):4824-7. doi: 10.1128/JCM.42.10.4824-4827.2004.
4
Proposal to accommodate Burkholderia cepacia genomovar VI as Burkholderia dolosa sp. nov.
Int J Syst Evol Microbiol. 2004 May;54(Pt 3):689-691. doi: 10.1099/ijs.0.02888-0.
5
Evidence of transmission of Burkholderia cepacia, Burkholderia multivorans and Burkholderia dolosa among persons with cystic fibrosis.
FEMS Microbiol Lett. 2003 Nov 7;228(1):57-62. doi: 10.1016/S0378-1097(03)00724-9.
6
Molecular characterization of Burkholderia cepacia isolates from cystic fibrosis (CF) patients in an Italian CF center.
Res Microbiol. 2003 Sep;154(7):491-8. doi: 10.1016/S0923-2508(03)00145-1.
7
Molecular typing of, and distribution of genetic markers among, Burkholderia cepacia complex isolates from Brazil.
J Clin Microbiol. 2003 Sep;41(9):4148-53. doi: 10.1128/JCM.41.9.4148-4153.2003.
8
Molecular analysis of Burkholderia cepacia complex isolates from a Portuguese cystic fibrosis center: a 7-year study.
J Clin Microbiol. 2003 Sep;41(9):4113-20. doi: 10.1128/JCM.41.9.4113-4120.2003.
9
Genomovar diversity amongst Burkholderia cepacia complex isolates from an Australian adult cystic fibrosis unit.
Eur J Clin Microbiol Infect Dis. 2003 Jul;22(7):434-7. doi: 10.1007/s10096-003-0949-8. Epub 2003 Jun 27.
10
Genomovar distribution of the Burkholderia cepacia complex differs significantly between Czech and Slovak patients with cystic fibrosis.
J Med Microbiol. 2003 Jul;52(Pt 7):603-604. doi: 10.1099/jmm.0.05163-0.
Zotero 插件